GLP1R and coronary artery disorder: Importantly, the presence of GLP1R in human cardiomyocytes adds anintriguing dimension to the potential cardiovascular impact of these medications.However, elevated circulating GLP-1 and GLP-2 and increased GLP-2R in EAT posequestions about the compensatory mechanisms involved in CAD and EAT expansion andrequire further exploration in future investigations.